鲁抗医药子公司获得非那雄胺片药品注册证书

Core Viewpoint - The company, LuKang Pharmaceutical (600789.SH), announced that its subsidiary, Shandong LuKang Pharmaceutical Group Sait Company, received a drug registration certificate from the National Medical Products Administration for Finasteride tablets, which is approved as a generic drug under the new registration classification 4 and has passed the consistency evaluation of quality and efficacy for generic drugs [1] Group 1 - The drug Finasteride is a synthetic steroid compound that specifically inhibits the enzyme type II 5α-reductase, which is involved in the metabolism of testosterone to dihydrotestosterone (DHT) [1] - Finasteride is effective in reducing DHT levels in blood and prostate, which is crucial for treating benign prostatic hyperplasia (BPH) [1] - The 1mg specification of Finasteride is indicated for the treatment of male pattern hair loss, promoting hair growth and preventing further hair loss, while the 5mg specification is used for treating and controlling BPH and preventing urinary system events [1]